Skip to main content
Premium Trial:

Request an Annual Quote

Expression Analysis to Provide Emory University with Gene Expression Services

NEW YORK, Aug. 18 (GenomeWeb News) - Expression Analysis has signed a multi-year agreement with EmoryUniversityto provide the school with gene expression services using Affymetrix' platform, EA said today.


In June, Durham, NC-based EA renewed and extended a similar agreement forged in 2001 with DukeUniversityMedicalCenter.


Kim Gernert, current director of Emory's Biomolecular Computing Resource, will serve as the gene expression analysis core facility program director, EA said.


Financial terms of the deal were not disclosed.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.